Quick Answer
enVVeno Medical Corp reported Stockholders Equity of $27.13 million for fiscal year 2025.
enVVeno Medical Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $27.13M | -35.6% |
| 2024 | $42.16M | -8.7% |
| 2023 | $46.20M | +19.3% |
| 2022 | $38.73M | -28.8% |
| 2021 | $54.40M | +666.5% |
| 2020 | $7.10M | +617.0% |
| 2019 | $989.9K | -51.4% |
| 2018 | $2.04M | +118.3% |
| 2017 | -$11.13M | -163.8% |
| 2016 | -$4.22M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $29.45M | -37.8% | -10.9% |
| June 30, 2025 | $33.06M | -14.0% | -13.7% |
| March 31, 2025 | $38.31M | -9.6% | -9.1% |
| December 31, 2024 | $42.16M | -8.7% | -11.0% |
| September 30, 2024 | $47.37M | +90.1% | +23.3% |
| June 30, 2024 | $38.42M | +33.3% | -9.3% |
| March 31, 2024 | $42.37M | +24.1% | -8.3% |
| December 31, 2023 | $46.20M | +19.3% | +85.4% |
- enVVeno Medical Corp showed a decrease of -35.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, enVVeno Medical Corp’s stockholders equity has grown by 743.0% (from -$4.22 million to $27.13 million).
- The most recent figure is from enVVeno Medical Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: